TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Aarti Drugs Limited ( (IN:AARTIDRUGS) ) has issued an update.
Aarti Drugs Limited has announced the opening of a special window for the re-lodgement of transfer requests of physical shares, as per the SEBI circular dated July 2, 2025. This move is significant for shareholders holding physical shares, as it aligns with regulatory requirements and facilitates smoother transactions, potentially enhancing shareholder value and compliance with market regulations.
More about Aarti Drugs Limited
Aarti Drugs Limited operates in the pharmaceutical industry, focusing on the manufacturing of active pharmaceutical ingredients (APIs), formulations, and specialty chemicals. The company serves a variety of markets, including domestic and international sectors, with a strong emphasis on quality and innovation in its product offerings.
Average Trading Volume: 33,496
Technical Sentiment Signal: Buy
Current Market Cap: 44.33B INR
See more insights into AARTIDRUGS stock on TipRanks’ Stock Analysis page.